New York State Common Retirement Fund’s OnKure Therapeutics OKUR Stock Holding History

New York State Common Retirement Fund’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.5K	Buy	+18,100	New	+$77.7K	﹤0.01%	2789
2024 Q3	–	Sell	-12	Closed	-$178	–	3361
2024 Q2	$178	Sell	12 -52	-81%	-$882	﹤0.01%	3377
2024 Q1	$1.06K	Buy	64 +42	+191%	+$693	﹤0.01%	3230
2023 Q4	$354	Sell	22 -2	-8%	-$125	﹤0.01%	3242
2023 Q3	$1.8K	Sell	24 -1,346	-98%	-$91.5K	﹤0.01%	3258
2023 Q2	$89.9K	Buy	+1,370	New	+$110K	﹤0.01%	2948
2022 Q3	–	Sell	-7	Closed	–	–	3478
2022 Q2	$0	Sell	7 -414	-98%	-$9.64K	﹤0.01%	3552
2022 Q1	$12K	Hold	421	–	–	﹤0.01%	3310
2021 Q4	$36K	Hold	421	–	–	﹤0.01%	3267
2021 Q3	$31K	Sell	421 -877	-68%	-$74.4K	﹤0.01%	3279
2021 Q2	$121K	Buy	+1,298	New	+$145K	﹤0.01%	3180

Other funds holding OKUR

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

TCOT

Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return

New York State Common Retirement Fund's OKUR Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in OnKure Therapeutics (OKUR) in Q2 2026: 18,100 shares worth $82.5K. The stake represents ﹤0.01% of the portfolio and ranks #2789 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in OKUR as recently as Q2 2024.

New York State Common Retirement Fund first reported a position in OKUR in Q2 2021 and has held it in 11 quarters since. The position peaked at $121K in Q2 2021. 5 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

New York State Common Retirement Fund held 18,100 shares of OnKure Therapeutics worth $82.5K as of Q2 2026.
OnKure Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
OnKure Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2789 holding.
New York State Common Retirement Fund first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 11 quarters since.
New York State Common Retirement Fund's OnKure Therapeutics position peaked at $121K in Q2 2021.
5 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.